Catalyst Wire Dossier Catalyst Wire Dossier

Dabigatran Etexilate (Dabigatran etexilate)

Dabigatran etexilate · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dabigatran Etexilate (Dabigatran etexilate), covering 2024-08-16 to 2024-08-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults [Phase 1]

See pricing